Expression of soluble CD137 correlates with activation-induced cell death of lymphocytes

Cytokine. 2000 Jun;12(6):742-6. doi: 10.1006/cyto.1999.0623.

Abstract

CD137 is a member of the tumour necrosis factor receptor family which delivers a potent co-stimulatory signal to T lymphocytes. Soluble forms of CD137 (sCD137) can be found at enhanced levels in sera of patients with rheumatoid arthritis. Here we show that expression of sCD137 lags behind that of membrane-bound CD137 (mCD137) by about 24 h. In fully activated lymphocytes, time of maximum increase and level of expression of sCD137 were at day 2 and 3, respectively. Expression of sCD137 in lymphocytes requires strong activation, and levels of sCD137 correlate negatively with lymphocyte proliferation and positively with the degree of activation-induced cell death caused by mitogen overstimulation. Since activation of lymphocytes through membrane-bound CD137 delivers a potent stimulatory signal, sCD137 may provide a negative control mechanism for immune responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD
  • Calcimycin / pharmacology
  • Cell Death
  • Cell Division
  • Flow Cytometry
  • Gene Expression Regulation / immunology*
  • Humans
  • Kinetics
  • Lymphocyte Activation*
  • Lymphocytes / cytology
  • Lymphocytes / immunology*
  • Phytohemagglutinins
  • Protein Isoforms / genetics
  • Receptors, Nerve Growth Factor / genetics*
  • Receptors, Tumor Necrosis Factor / genetics*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tumor Necrosis Factor Receptor Superfamily, Member 9

Substances

  • Antigens, CD
  • Phytohemagglutinins
  • Protein Isoforms
  • Receptors, Nerve Growth Factor
  • Receptors, Tumor Necrosis Factor
  • TNFRSF9 protein, human
  • Tumor Necrosis Factor Receptor Superfamily, Member 9
  • Calcimycin
  • Tetradecanoylphorbol Acetate